Document:

Exhibit
10.1

 

SECURITIES
PURCHASE AGREEMENT

 

This
Securities Purchase Agreement (this “Agreement”) is made as of January 19, 2021, by and among Taoping Inc.,
a BVI business company (the “Company”) and each investor identified on the signature pages hereto (each, including
its successors and assigns, an “Investor” and collectively the “Investors”).

 

WHEREAS,
subject to the terms and conditions set forth in this Agreement and pursuant to an effective Registration Statement under the
Securities Act of 1933, as amended (the “Securities Act”), the Company desires to issue and sell to the Investors,
and each of the Investors desires to purchase from the Company certain securities of the Company, as more fully described in this
Agreement, and

 

NOW,
THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and for other good and valuable consideration,
the receipt and adequacy of which are hereby acknowledged, the Company and each Investor agree as follows:

 

ARTICLE
1.

DEFINITIONS

 

1.1.
Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following
terms shall have the meanings indicated in this Section 1.1:

 

“Action”
means any action, suit, inquiry, notice of violation, proceeding (including any partial proceeding such as a deposition) or investigation
pending or threatened in writing against or affecting the Company, any of the Subsidiaries and Affiliated Entities or any of their
respective properties before or by any court, arbitrator, governmental or administrative agency, regulatory authority (federal,
state, county, local or foreign), stock market, stock exchange or trading facility.

 

“Affiliate”
means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common
control with a Person, as such terms are used in and construed under Rule 144 (as defined below).

 

“Affiliated
Entities” means the entities through which the Company conducts its operations in the People’s Republic of China
(the “PRC”) by way of contractual arrangements.

 

“Business
Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York or Shenzhen,
PRC are authorized or required by law to remain closed; provided, however, for clarification, commercial banks shall
not be deemed to be authorized or required by law to remain closed due to “stay at home”, “shelter-in-place”,
“non-essential employee” or any other similar orders or restrictions or the closure of any physical branch locations
at the direction of any governmental authority so long as the electronic funds transfer systems (including for wire transfers)
of commercial banks in The City of New York or Shenzhen, PRC generally are open for use by customers on such day.

 

“Closing
Date” means a Trading Day no later than the second (2nd) Trading Day following the date hereof on which all of the Transaction
Documents have been executed and delivered by the applicable parties thereto, and all conditions precedent to (i) each Investor’s
obligations to pay the Subscription Amount and (ii) the Company’s obligations to deliver the Shares to each Investor, in
each case, have been satisfied or waived.

 

    	 	 	 

    	 	 	 

    

 

“Commission”
means the Securities and Exchange Commission.

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

“GAAP”
means U.S. generally accepted accounting principles.

 

“Governmental
Body” shall mean any: (a) nation, state, commonwealth, province, territory, county, municipality, district or other
jurisdiction of any nature; (b) federal, state, local, municipal, foreign or other government; or (c) governmental or quasi-governmental
authority of any nature (including any governmental or administrative division, department, agency, commission, instrumentality,
official, organization, unit, body or entity) and any court or other tribunal.

 

“Lien”
means any lien, charge, encumbrance, security interest, right of first refusal, right of participation or other restrictions
of any kind.

 

“Material
Adverse Effect” means any of (i) a material and adverse effect on the legality, validity or enforceability of any Transaction
Document, (ii) a material and adverse effect on the results of operations, assets, prospects, business or condition (financial
or otherwise) of the Company and the Subsidiaries and Affiliated Entities, taken as a whole, or (iii) an adverse impairment to
the Company’s ability to perform on a timely basis its obligations under any Transaction Document.

 

“New
York Courts” means the state and federal courts sitting in the City of New York, Borough of Manhattan.

 

“Ordinary
Shares” means the ordinary shares of the Company of no par value each, and any securities into which such ordinary shares
may hereafter be reclassified or for which it may be exchanged as a class.

 

“Ordinary
Shares Equivalents” means any securities of the Company which entitle the holder thereof to acquire Ordinary Shares
at any time, including without limitation, any debt, preferred stock, rights, options, warrants or other instrument that is at
any time convertible into or exchangeable for, or otherwise entitles the holder thereof to receive, Ordinary Shares or other securities
that entitle the holder to receive, directly or indirectly, Ordinary Shares.

 

“Person”
means an individual or corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited
liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind.

 

“Principal
Market” means The Nasdaq Capital Market.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition), whether commenced or threatened.

 

    	 	2	 

    	 	 	 

    

 

“Prospectus”
means the final prospectus filed for the Registration Statement.

 

“Prospectus
Supplement” means the supplement to the Prospectus complying with Rule 424(b) of the Securities Act that is filed with
the Commission and delivered by the Company to the Investors at the Closing.

 

“Registration
Statement” means the effective registration statement with Commission file No. 333-229323 which registers the sale of
the Shares to the Investors.

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Shares”
means an aggregate of 740,740 Ordinary Shares issued or issuable to the Investors pursuant to this Agreement.

 

“Short
Sales” means all “short sales” as defined in Rule 200 promulgated under Regulation SHO under the Exchange
Act.

 

“Subsidiary”
means any “significant subsidiary” as defined in Rule 1-02(w) of the Regulation S-X promulgated by the Commission
under the Exchange Act.

 

“Subscription
Amount” means the aggregate amount to be paid for the Shares purchased hereunder as specified below the Investor’s
name on the signature page of this Agreement and next to the heading “Subscription Amount” in immediately available
funds.

 

“Trading
Day” means, as applicable, (x) with respect to all price or trading volume determinations relating to the Ordinary Shares,
any day on which the Ordinary Shares is traded on the Principal Market, or, if the Principal Market is not the principal trading
market for the Ordinary Shares, then on the principal securities exchange or securities market on which the Ordinary Shares are
then traded, provided that “Trading Day” shall not include any day on which the Ordinary Shares are scheduled to trade
on such exchange or market for less than 4.5 hours or any day that the Ordinary Shares are suspended from trading during the final
hour of trading on such exchange or market (or if such exchange or market does not designate in advance the closing time of trading
on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time) unless such day is otherwise designated
as a Trading Day in writing by any Investor or (y) with respect to all determinations other than price or trading volume determinations
relating to the Ordinary Shares, any day on which The New York Stock Exchange (or any successor thereto) is open for trading of
securities.

 

“Trading
Market” means whichever of the New York Stock Exchange, the NYSE American, the NASDAQ Global Select Market, the NASDAQ
Global Market, the Principal Market or OTC Markets on which the Ordinary Shares are listed or quoted for trading on the date in
question.

 

“Transaction
Documents” means this Agreement, all exhibits and schedules thereto and hereto and any other documents or agreements
executed in connection with the transactions contemplated hereunder.

 

    	 	3	 

    	 	 	 

    

 

“Transfer
Agent” means Transhare Corporation, the current transfer agent of the Company, with a mailing address of 2849 Executive
Dr., Suite 200, Clearwater FL 33762, and any successor transfer agent of the Company.

 

ARTICLE
2.

PURCHASE AND SALE

 

2.1.
Subscription for Shares by the Investors. Subject to the terms and conditions set forth in this Agreement, including all
of the conditions set forth in Sections 5.1 and 5.2 hereof, on the Closing Date, the Company shall issue and sell to each Investor,
and each Investor severally, but not jointly, agrees to purchase from the Company such aggregate number of Shares at the Subscription
Amount as set forth on such Investor’s signature page hereto.

 

2.2.
Closing. The sale of the Shares will take place in a closing (the “Closing”), subject to the satisfaction
of the parties hereto of their obligations herein. The Closing shall be conducted by exchange of original documents or electronic
documents following the fulfillment or waiver of the conditions to closing as set forth in Article 5 on the Closing Date.

 

2.3.
Closing Deliveries.

 

(a)
At the Closing, the Company shall deliver or cause to be delivered to each Investor the following (the “Company Deliverables”):

 

(i)
a copy of instructions to the Transfer Agent instructing the Transfer Agent to update the register of member to reflect the issue
of the Shares and deliver the Shares in an amount specified on the signature page of such Investor and registered in the name
of such Investor;

 

(ii)
this Agreement duly signed by the Company; and

 

(iii)
the Prospectus and Prospectus Supplement (which may be delivered in accordance with Rule 172 under the Securities Act).

 

(b)
At the Closing, each Investor shall deliver or cause to be delivered the following (collectively, the “Investor Deliverables”):

 

(i)
the Subscription Amount, payable at the Investor’s option in United States Dollar or the equivalent amount in Renminbi based
on the central parity rate of Renminbi against the United States Dollar published by the People’s Bank of China on the Closing
Date, in immediately available funds, by wire transfer to an account designated in writing by an authorized representative of
the Company for such purpose at least three (3) Business Days prior to the Closing; and

 

(ii)
this Agreement duly signed by each Investor.

 

    	 	4	 

    	 	 	 

    

 

ARTICLE
3.

REPRESENTATIONS AND WARRANTIES

 

3.1.
Representations and Warranties of the Company. The Company hereby makes the following representations and warranties to
the Investors as of the date hereof and the Closing Date:

 

(a)
Subsidiaries and Affiliated Entities. The Company has no direct or indirect Subsidiaries or Affiliated Entities other than
as specified in the SEC Reports (as defined below).

 

(b)
Organization and Qualification. The Company and each of the Subsidiaries and Affiliated Entities are duly incorporated
or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization
(as applicable), with the requisite power and authority to own and use its properties and assets and to carry on its business
as currently conducted. None of the Company, the Subsidiaries and the Affiliated Entities is in violation of any of the provisions
of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company,
the Subsidiaries and Affiliated Entities is duly qualified to conduct its respective businesses and are in good standing as a
foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it
makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could
not, individually or in the aggregate, have or reasonably be expected to result in a Material Adverse Effect.

 

(c)
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by each of the Transaction Documents and otherwise to carry out its obligations thereunder. The
execution and delivery of each of the Transaction Documents by the Company and the consummation by it of the transactions contemplated
thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the
Company in connection therewith. Each Transaction Document has been (or upon delivery will have been) duly executed by the Company
and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the Company enforceable
against the Company in accordance with its terms, except as such enforceability may be limited by applicable bankruptcy, insolvency,
reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’
rights and remedies or by other equitable principles of general application.

 

(d)
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation
by the Company of the transactions contemplated thereby do not and will not (i) conflict with or violate any provision of the
Company’s, any Subsidiary’s or any Affiliated Entity’s certificate or articles of incorporation, bylaws or other
organizational or charter documents as in effect on the date hereof, or (ii) conflict with, or constitute a default (or an event
that with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment,
acceleration or cancellation (with or without notice, lapse of time or both) of, any material agreement, credit facility, debt
or other instrument (evidencing a Company, Subsidiary or Affiliated Entity debt or otherwise) or other understanding to which
the Company or any of the Subsidiaries and Affiliated Entities is a party or by which any property or asset of the Company or
any of the Subsidiaries and Affiliated Entities is bound or affected, or (iii) result in a material violation of any law, rule,
regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company
or any of the Subsidiaries and Affiliated Entities is subject (including federal and state securities laws and regulations), or
by which any property or asset of the Company or any of the Subsidiaries and Affiliated Entities is bound or affected.

 

    	 	5	 

    	 	 	 

    

 

(e)
Filings, Consents and Approvals. Except as set forth in the SEC Reports (as defined below), the Company is not required
to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any United
States or PRC court or other federal, state, local or other governmental authority or other Person in connection with the execution,
delivery and performance by the Company of the Transaction Documents, other than (i) the filing with the Commission of the Prospectus
Supplement, (ii) filings required by state securities laws, (iii) if required, filings with each applicable Trading Market for
the issuance and sale of the Shares in the time and manner required thereby, and (iv) the filings required in accordance with
Section 4.1 and (v) those that have been made or obtained prior to the date of this Agreement.

 

(f)
Issuance of the Shares. The Shares are duly authorized and, when issued and paid for in accordance with the applicable
Transaction Documents, will be duly and validly issued, fully paid and nonassessable, free and clear of all Liens. The Registration
Statement is effective under the Securities Act and no stop order preventing or suspending the effectiveness of the Registration
Statement or suspending or preventing the use of the Prospectus has been issued by the Commission and no proceedings for that
purpose have been instituted or, to the knowledge of the Company, are threatened by the Commission.

 

(g)
Capitalization. The number of securities and type of all authorized, issued and outstanding capital stock of the Company,
all Ordinary Shares reserved for issuance under the Company’s various option and incentive plans, all shares of capital
stock of the Company issuable and reserved for issuance pursuant to securities exercisable for, or convertible into or exchangeable
for any shares of capital stock of the Company, and all Ordinary Shares reserved for issuance pursuant to the Company’s
existing contractual obligations as of the date hereof , is specified in the SEC Reports. Except as specified in the SEC Reports
in connection with the Company’s variable interest entity structure, no securities of the Company are entitled to preemptive
or similar rights, and no Person has any right of first refusal, preemptive right, right of participation, or any similar right
to participate in the transactions contemplated by the Transaction Documents. Except as specified in the SEC Reports, there are
no outstanding options, warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to,
or securities, rights or obligations convertible into or exchangeable for, or giving any Person any right to subscribe for or
acquire, any Ordinary Shares, or contracts, commitments, understandings or arrangements by which the Company or any of the Subsidiaries
and Affiliated Entities is or may become bound to issue additional Ordinary Shares, or securities or rights convertible or exchangeable
into Ordinary Shares.

 

    	 	6	 

    	 	 	 

    

 

(h)
SEC Reports; Financial Statements. To the best knowledge of the Company after due inquiry with its securities advisors,
the Company has filed all reports required to be filed by it under the Securities Act and the Exchange Act, including pursuant
to Section 13(a) or 15(d) thereof, for the twelve months preceding the date hereof (or such shorter period as the Company was
required by law to file such reports) (the foregoing materials, including the exhibits thereto and documents incorporated by reference
therein, being collectively referred to herein as the “SEC Reports”) on a timely basis or has timely filed
a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any such extension. As
of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the
Exchange Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed,
contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary
in order to make the statements therein, in light of the circumstances under which they were made, not materially misleading.
The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting
requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial
statements have been prepared in accordance with GAAP applied on a consistent basis during the periods involved, except as may
be otherwise specified in such financial statements or the notes thereto, and fairly present in all material respects the financial
position of the Company and its consolidated Subsidiaries and Affiliated Entities as of and for the dates thereof and the results
of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial,
year-end audit adjustments.

 

(i)
Litigation. There is no Action which (i) adversely affects or challenges the legality, validity or enforceability of any
of the Transaction Documents or the Shares or (ii) could, if there were an unfavorable decision, individually or in the aggregate,
have or reasonably be expected to materially impact the business of the Company or any of its Subsidiaries and Affiliated Entities.
Neither the Company nor any of the Subsidiaries and Affiliated Entities, nor any director or officer thereof (in his or her capacity
as such), is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities
laws or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending any
investigation by the Commission involving the Company or any current or former director or officer of the Company (in his or her
capacity as such). The Commission has not issued any stop order or other order suspending the effectiveness of any registration
statement filed by the Company or any of the Subsidiaries and Affiliated Entities under the Exchange Act or the Securities Act.

 

(j)
Compliance. Neither the Company nor any of the Subsidiaries and Affiliated Entities (i) is in material default under or
in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in
a material default by the Company or any of the Subsidiaries and Affiliated Entities under), nor has the Company or any of the
Subsidiaries and Affiliated Entities received notice of a claim that it is in material default under or that it is in violation
of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any
of its properties is bound (whether or not such default or violation has been waived), (ii) is in violation of any order of any
material court, arbitrator or Governmental Body, or (iii) is or has been in material violation of any statute, rule or regulation
of any governmental authority, including without limitation all foreign, federal, state and local laws relating to the business
of the Company, the Subsidiaries and Affiliated Entities, taxes, environmental protection, occupational health and safety, product
quality and safety, licensure and employment and labor matters (including social insurance and housing funds).

 

(k)
Regulatory Permits. The Company, the Subsidiaries and Affiliated Entities possess all material certificates, authorizations
and permits issued by the appropriate federal, state, local or foreign regulatory authorities necessary to conduct their respective
businesses as described in the SEC Reports, and neither the Company nor any of the Subsidiaries and Affiliated Entities has received
any notice of proceedings relating to the revocation or modification of any such permits.

 

    	 	7	 

    	 	 	 

    

 

(l)
Title to Assets. The Company and each of the Subsidiaries and Affiliated Entities have valid land use rights for all real
property owned by them that is material to their respective businesses and good and marketable title in all personal property
owned by them that is material to their respective businesses, in each case free and clear of all Liens, except for Liens as do
not materially affect the value of such property and do not materially interfere with the use made and proposed to be made of
such property by the Company and each of the Subsidiaries and Affiliated Entities. Any real property and facilities held under
lease by the Company and any of the Subsidiaries and Affiliated Entities are held by them under valid, subsisting and enforceable
leases of which the Company and each of the Subsidiaries and Affiliated Entities are in material compliance.

 

(m)
Material Changes; Undisclosed Events. Since the date of the latest audited financial statements included within the SEC
Reports, except as specifically disclosed in a subsequent SEC Report filed prior to the date hereof, (i) there has been no event,
occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect, (ii) neither
the Company nor any of the Subsidiaries and Affiliated Entities has incurred any material liabilities (direct, indirect, contingent,
or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with past
practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed
in filings made with the Commission, (iii) the Company has not altered its method of accounting, (iv) the Company has not declared
or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements
to purchase or redeem any shares of its capital stock, (v) neither the Company nor any of the Subsidiaries and Affiliated Entities
has waived any material right or material debt owed to it, (vi) neither the Company nor any of the Subsidiaries and Affiliated
Entities has changed or amended its certificate or articles of incorporation, bylaws or other organizational or charter documents,
or change any material contract or arrangement by which the Company or any of the Subsidiaries and Affiliated Entities is bound
or to which its assets or properties is subject, and (vii) the Company has not issued any equity securities to any officer, director,
consultant or Affiliate of the Company or any of the Subsidiaries and Affiliated Entities, except pursuant to existing Company
equity incentive plans or consulting agreements. The Company does not have pending before the Commission any request for confidential
treatment of information. Neither the Company nor any of the Subsidiaries and Affiliated Entities have any liabilities or obligations
required to be disclosed in the SEC Reports which are not so disclosed in the SEC Reports, other than those incurred in the ordinary
course of the Company’s or any of the Subsidiaries and Affiliated Entities’ respective businesses and which, individually
or in the aggregate, do not or would not reasonably be expected to have a Material Adverse Effect.

 

(n)
Patents and Trademarks. The Company and its Subsidiaries and Affiliated Entities have, or have rights to use, all patents,
patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions, copyrights, licenses
and other intellectual property rights and similar rights as described in the SEC Reports as necessary or material for use in
connection with their respective businesses (collectively, the “Intellectual Property Rights”). Neither the
Company nor any of the Subsidiaries and Affiliated Entities has received notice (written or otherwise) that any of the Intellectual
Property Rights used by the Company or any of the Subsidiaries and Affiliated Entities violates or infringes upon the rights of
any Person. To the knowledge of the Company, all such Intellectual Property Rights are enforceable and there is no existing infringement
by another Person of any of the Intellectual Property Rights. The Company and its Subsidiaries and Affiliated Entities have taken
reasonable security measures to protect the secrecy, confidentiality and value of all of their intellectual properties.

 

    	 	8	 

    	 	 	 

    

 

(o)
Sarbanes-Oxley; Internal Accounting Controls. Except as set forth in the SEC Reports, to the best of the Company’s
knowledge, the Company and each of the Subsidiaries and Affiliated Entities are in compliance with any and all applicable requirements
of the Sarbanes-Oxley Act of 2002 that are effective as of the date hereof, and any and all applicable rules and regulations promulgated
by the Commission thereunder that are effective as of the date hereof and as of the applicable Closing Date.

 

(p)
Tax Status. The Company and each of the Subsidiaries and Affiliated Entities have filed all material and necessary federal,
state and foreign income and franchise tax returns and have paid or accrued all taxes shown as due thereon, and to the knowledge
of the Company, the Company has no tax deficiency which has been asserted or threatened against the Company or any of the Subsidiaries
and Affiliated Entities.

 

(q)
Solvency. Based on the financial condition of the Company as of the Closing Date (and assuming that the Closing shall have
occurred), (i) the Company’s fair saleable value of its assets exceeds the amount that will be required to be paid on or
in respect of the Company’s existing debts and other liabilities (including known contingent liabilities) as they mature,
(ii) the Company’s assets do not constitute unreasonably small capital to carry on its business for the current fiscal year
as now conducted and as proposed to be conducted including its capital needs taking into account the particular capital requirements
of the business conducted by the Company, and projected capital requirements and capital availability thereof, and (iii) the current
cash flow of the Company, together with the proceeds the Company would receive, were it to liquidate all of its assets, after
taking into account all anticipated uses of the cash, would be sufficient to pay all amounts on or in respect of its debt when
such amounts are required to be paid. The Company does not intend to incur debts beyond its ability to pay such debts as they
mature (taking into account the timing and amounts of cash to be payable on or in respect of its debt).

 

(r)
Investment Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Shares,
will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940,
as amended.

 

(s)Listing
and Maintenance Requirements. The Ordinary Shares are registered pursuant to Section 12(b) of the Exchange Act, and the Company
has taken no action designed to, or which to the knowledge of the Company is likely to have the effect of, terminating the registration
of the Ordinary Shares under the Exchange Act nor has the Company received any notification that the Commission is contemplating
terminating such registration. Except as specifically disclosed in the SEC Reports, the Company has not, in the 12 months preceding
the date hereof, received notice from any Trading Market on which the Ordinary Shares are or have been listed or quoted to the
effect that the Company is not in compliance with the listing or maintenance requirements of such Trading Market. `

 

    	 	9	 

    	 	 	 

    

 

(t)
Money Laundering. The Company and each of the Subsidiaries and Affiliated Entities are in compliance with, and have not
previously violated, the USA Patriot Act of 2001 and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations,
including, without limitation, the laws, regulations and Executive Orders and sanctions programs administered by the U.S. Office
of Foreign Assets Control, including, but not limited, to (i) Executive Order 13224 of September 23, 2001 entitled, “Blocking
Property and Prohibiting Transactions With Persons Who Commit, Threaten to Commit, or Support Terrorism” (66 Fed. Reg. 49079
(2001)); and (ii) any regulations contained in 31 CFR, Subtitle B, Chapter V.

 

(u)
Application of Takeover Protections. The Company has taken all necessary action in order to render inapplicable any control
share acquisition, business combination, poison pill (including any distribution under a rights agreement) or other similar anti-takeover
provision under the Company’s memorandum and articles of association or the British Virgin Islands laws that is or could
become applicable to the Investors as a result of the Investors and the Company fulfilling their obligations or exercising their
rights under the Transaction Documents, including without limitation as a result of the Company’s issuance of the Shares
and the Investors’ ownership of the Shares.

 

(v)
No Integrated Offering. Assuming the accuracy of the Investors’ representations and warranties set forth in Section
3.2, neither the Company, nor any of its Affiliates, nor any Person acting on its or their behalf has, directly or indirectly,
made any offers or sales of any security or solicited any offers to buy any security, under circumstances that would cause this
offering of the Shares to be integrated with prior offerings by the Company for purposes of (i) the Securities Act which would
require the registration of any such securities under the Securities Act, or (ii) any applicable shareholder approval provisions
of any Trading Market on which any of the securities of the Company are listed or designated.

 

(w)
No Additional Agreements. The Company does not have any agreement or understanding with any Investor with respect to the
transactions contemplated by the Transaction Documents other than as specified in the Transaction Documents.

 

(x)
Disclosure. The Company confirms that neither it nor any Person acting on its behalf has provided any Investor or its respective
agents or counsel with any information that the Company believes constitutes material, non-public information concerning the Company,
the Subsidiaries and Affiliated Entities or their respective businesses, except insofar as the existence and terms of the proposed
transactions contemplated hereunder may constitute such information. The Company understands and confirms that the Investor will
rely on the foregoing representations and covenants in effecting transactions in securities of the Company. All disclosure provided
to the Investors regarding the Company, each of the Subsidiaries and Affiliated Entities or their respective businesses and the
transactions contemplated hereby, furnished by or on behalf of the Company (including the Company’s representations and
warranties set forth in this Agreement) are true and correct and do not contain any untrue statement of a material fact or omit
to state any material fact necessary in order to make the statements made therein, in light of the circumstances under which they
were made, not misleading.

 

    	 	10	 

    	 	 	 

    

 

Each
Investor acknowledges and agrees that the Company has not made nor makes any representations or warranties with respect to the
transactions contemplated hereby other than those specifically set forth in this Section 3.1.

 

3.2.
Representations and Warranties of the Investor. Each Investor hereby represents and warrants to the Company as of the date
hereof and the Closing Date:

 

(a)
Organization; Authority. Investor is either an individual or an entity duly incorporated or formed, validly existing and
in good standing under the laws of the jurisdiction of its incorporation or formation with full right, corporate, partnership,
limited liability company or similar power and authority to enter into and to consummate the transactions contemplated by the
Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. The execution and delivery of the Transaction
Documents and performance of the transactions contemplated by the Transaction Documents have been duly authorized by all necessary
corporate, partnership, limited liability company or similar action, as applicable, on the part of Investor. Each Transaction
Document to which it is a party has been duly executed by Investor, and when delivered by Investor in accordance with the terms
hereof, will constitute the valid and legally binding obligation of Investor, enforceable against it in accordance with its terms,
except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other
laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the
availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.

 

(b)
Access to Information. Investor acknowledges that it has reviewed the SEC Reports and has been afforded (i) the opportunity
to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the
terms and conditions of the offering of the Shares and the merits and risks of investing in the Shares; (ii) access to information
about the Company and each of the Subsidiaries and Affiliated Entities and their respective financial condition, results of operations,
business, properties, management and prospects sufficient to enable it to evaluate its investment; and (iii) the opportunity to
obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary
to make an informed investment decision with respect to the investment. Neither such inquiries nor any other investigation conducted
by or on behalf of such Investor or its representatives or counsel shall modify, amend or affect such Investor’s right to
rely on the truth, accuracy and completeness of the SEC Reports and the Company’s representations and warranties contained
in the Transaction Documents.

 

(c)
No Conflicts. The execution, delivery and performance by such Investor of any Transaction Document and the consummation
by such Investor of the transactions contemplated hereby will not (i) result in a violation of the organizational documents of
such Investor, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become
a default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture
or instrument to which such Investor is a party or (iii) result in a violation of any law, rule, regulation, order, judgment or
decree (including federal and state securities laws) applicable to such Investor, except, in the case of clauses (ii) and (iii)
above, for such conflicts, defaults, rights or violations which would not, individually or in the aggregate, reasonably be expected
to have a material adverse effect on the ability of such Investor to perform its obligations hereunder.

 

    	 	11	 

    	 	 	 

    

 

(d)
Certain Trading Activities. Investor has not directly or indirectly, nor has any Person acting on behalf of or pursuant
to any understanding with Investor, engaged in any transactions in the securities of the Company (including, without limitations,
any Short Sales involving the Company’s securities) since the time that Investor was first contacted by the Company regarding
an investment in the Company. Investor covenants that neither it nor any Person acting on its behalf or pursuant to any understanding
with it will engage in any transactions in the securities of the Company (including Short Sales) prior to the time that the transactions
contemplated by this Agreement are publicly disclosed.

 

The
Company acknowledges and agrees that Investors have not made or do not make any representations or warranties with respect to
the transactions contemplated hereby other than those specifically set forth in this Section 3.2.

 

ARTICLE
4.

OTHER AGREEMENTS OF THE PARTIES

 

4.1.
Securities Laws Disclosure; Publicity. On or before 9:30 a.m., New York time, on or before the second (2nd)
Business Day after the date of this Agreement, the Company shall publicly disclose the material terms of the transactions contemplated
hereby to the extent required by the Exchange Act. The Company covenants that following such disclosure, no Investor shall be
in possession of any material, non-public information with respect to the Company or any of the Subsidiaries and Affiliated Entities.

 

4.2.
Indemnification of Investors. The Company will indemnify and hold each Investor and its directors, officers, shareholders,
partners, members, affiliates, employees and agents (each, an “Investor Party”) harmless from any and all direct
and indirect losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts
paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation in respect thereof (collectively,
“Losses”) that any such Investor Party may suffer or incur as a result of or relating to any misrepresentation,
breach or inaccuracy of any representation, warranty, covenant or agreement made by any of the Company in any Transaction Document.
In addition to the indemnity contained herein, the Company will reimburse each Investor Party for its reasonable legal and other
expenses (including the cost of any investigation, preparation and travel in connection therewith) incurred in connection therewith,
as such expenses are incurred.

 

4.3.
Non-Public Information. The Company covenants and agrees that neither it nor any other Person acting on its behalf will
provide each Investor or its agents or counsel with any information that the Company believes constitutes material non-public
information, unless prior thereto such Investor shall have executed a written agreement regarding the confidentiality and use
of such information. The Company understands and confirms that each Investor shall be relying on the foregoing representations
in effecting transactions in securities of the Company.

 

4.4.
Use of Proceeds. The Company will use the proceeds from the sale of the Shares for working capital and general corporate
purposes, and shall not use such proceeds: (a) for the satisfaction of any portion of the Company’s debt (other than payment
of trade payables in the ordinary course of business and prior practices of the Company and its Subsidiaries and Affiliated Entities,
(b) for the redemption of any Ordinary Shares or Ordinary Shares Equivalents, or (c) for the settlement of any outstanding litigation.

 

    	 	12	 

    	 	 	 

    

 

ARTICLE
5.

CONDITIONS PRECEDENT TO CLOSING

 

5.1.
Conditions Precedent to the Obligations of the Investors to Purchase the Shares. The obligation of each Investor to acquire
the Shares at the Closing is subject to the satisfaction or waiver by such Investor, at or before the Closing, of each of the
following conditions:

 

(a)
Representations and Warranties. The representations and warranties of the Company contained herein (a) that are not qualified
by materiality, Material Adverse Effect or a similar materiality qualifier shall be true and correct in all material respects
both when made and on the Closing Date with the same force and effect as if made as of the Closing Date and (b) that are qualified
by materiality, Material Adverse Effect or a similar materiality qualifier shall be true and correct in all respects both when
made and on the Closing Date with the same force and effect as if made as of the Closing Date, other than such representations
and warranties that expressly speak only as of a specific date or time, which shall be true and correct as of such specified date
or time;

 

(b)
Performance. The Company shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or prior to the Closing;

 

(c)
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any
of the transactions contemplated by the Transaction Documents;

 

(d)
No Suspensions of Trading in Ordinary Shares; Listing. Trading in the Ordinary Shares shall not have been suspended by
the Commission, any Trading Market or any Governmental Body (except for any suspensions of trading of not more than one Trading
Day solely to permit dissemination of material information regarding the Company) at any time since the date of execution of this
Agreement, the Ordinary Shares shall have been at all times since such date listed for trading on a Trading Market, and the Company
shall not have received notice of any delisting or removal from trading on any Trading Market except as otherwise disclosed prior
to the date hereof in SEC Reports;

 

(e)
Adverse Changes. Since the date of execution of this Agreement, no event or series of events shall have occurred that reasonably
could have or result in a Material Adverse Effect or a material adverse change with respect to the Company; and

 

(f)
Company Deliverables. The Company shall have delivered the Company Deliverables in accordance with Section 2.3(a).

 

    	 	13	 

    	 	 	 

    

 

5.2.
Conditions Precedent to the Obligations of the Company to Sell the Shares. The obligation of the Company to sell and issue
the Shares to each Investor at the Closing is subject to the satisfaction or waiver by the Company, at or before the Closing,
of each of the following conditions:

 

(a)
Representations and Warranties. The representations and warranties of the Investors contained herein (a) that are not qualified
by materiality, Material Adverse Effect or a similar materiality qualifier shall be true and correct in all material respects
both when made and on the Closing Date with the same force and effect as if made as of the Closing Date and (b) that are qualified
by materiality, Material Adverse Effect or a similar materiality qualifier shall be true and correct in all respects both when
made and on the Closing Date with the same force and effect as if made as of the Closing Date, other than such representations
and warranties that expressly speak only as of a specific date or time, which shall be true and correct as of such specified date
or time;

 

(b)
Performance. Each Investor shall have performed, satisfied and complied in all material respects with all covenants, agreements
and conditions required by the Transaction Documents to be performed, satisfied or complied with by such Investor at or prior
to the Closing;

 

(c)
No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any
of the transactions contemplated by the Transaction Documents; and

 

(d)
Investor Deliverables. Each Investor shall have delivered its Investor Deliverables in accordance with Section 2.3(b).

 

ARTICLE
6.

MISCELLANEOUS

 

6.1.
Fees and Expenses. Each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts,
if any, and all other expenses incurred by such party incident to the negotiation, preparation, execution, delivery and performance
of the Transaction Documents.

 

6.2.
Termination. This Agreement may be terminated by any Investor or the Company by written notice to the other party, if the
Closing has not been consummated on or before March 31, 2021; provided, however, that such termination will not affect the right
of any party to sue for any breach by any other party.

 

6.3.
Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding
of the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and representations,
oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and
schedules.

 

    	 	14	 

    	 	 	 

    

 

6.4.
Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall
be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication
is delivered via (i) facsimile (provided the sender receives a machine-generated confirmation of successful transmission) at the
facsimile number specified in this Section or (ii) electronic mail (i.e., Email) prior to 5:30 p.m. (New York City time) on a
Business Day, (b) the next Business Day after the date of transmission, if such notice or communication is delivered via (i) facsimile
at the facsimile number specified in this Section or (ii) electronic mail (i.e., Email) on a day that is not a Business Day or
later than 5:30 p.m. (New York City time) on any Business Day, or (c) the Business Day following the date of mailing, if sent
by U.S. or PRC nationally recognized overnight courier service, or (d) upon actual receipt by the party to whom such notice is
required to be given, if sent by any means other than facsimile or Email transmission. The address for such notices and communications
shall be as follows:

 

	If
    to the Company:	Taoping
    Inc.
	 	21st
    Floor, Everbright Bank Building
	 	Zhuzilin,
    Futian District
	 	Shenzhen,
    Guangdong 518040
	 	People’s
    Republic of China
	 	Attn.:
    President
	 	Facsimile:
    86-755-8370-9333
	 	E-mail:
    ir@taoping.cn
	 	 
	If
    to any Investor:	To
    the address set forth under such Investor’s name on the signature pages hereof;

 

or
such other address as may be designated in writing hereafter, in the same manner, by such Person.

 

6.5.
Amendments; Waivers; No Additional Consideration. No provision of this Agreement may be waived or amended except in a written
instrument signed, in the case of an amendment, by the Company and the Investors, in the case of a waiver, by the party against
whom enforcement of any such waiver is sought. No waiver of any default with respect to any provision, condition or requirement
of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of
any other provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder
in any manner impair the exercise of any such right.

 

6.6.
Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be
deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language
chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. This
Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring
or disfavoring any party by virtue of the authorship of any provisions of this Agreement or any of the Transaction Documents.

 

6.7.
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors
and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written
consent of each Investor. Any Investor may assign any or all of its rights under this Agreement to any Person to whom such Investor
assigns or transfers any Shares, provided that such transferee agrees in writing to be bound, with respect to the transferred
Shares, by the provisions hereof that apply to the “Investor.”

 

    	 	15	 

    	 	 	 

    

 

6.8.
No Third-Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective successors
and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as
otherwise set forth in Section 4.2.

 

6.9.
Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall
be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the
principles of conflicts of law thereof. Each party agrees that all Proceedings concerning the interpretations, enforcement and
defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party
hereto or its respective Affiliates, employees or agents) shall be commenced exclusively in the New York Courts. Each party hereto
hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder
or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement
of the any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim
that it is not personally subject to the jurisdiction of any such New York Court, or that such Proceeding has been commenced in
an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal service of process and consents to process
being served in any such Proceeding by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence
of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall
constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any
way any right to serve process in any manner permitted by law. Each party hereto hereby irrevocably waives, to the fullest extent
permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or relating to this Agreement
or the transactions contemplated hereby. If either party shall commence a Proceeding to enforce any provisions of a Transaction
Document, then the prevailing party in such Proceeding shall be reimbursed by the other party for its reasonable attorneys’
fees and other costs and expenses incurred with the investigation, preparation and prosecution of such Proceeding.

 

6.10.
Survival. The representations and warranties contained herein shall survive the Closing and the delivery of the Shares,
until the second anniversary of the date hereof. The covenants contained herein shall survive the Closing until they are satisfied
in full.

 

6.11.
Execution. This Agreement may be executed and delivered (including by facsimile transmission and electronic mail attaching
a portable document file (.pdf)) in one or more counterparts and all of which when taken together shall be considered one and
the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party,
it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by facsimile
transmission or electronic mail attachment, such signature shall create a valid and binding obligation of the party executing
(or on whose behalf such signature is executed) with the same force and effect as if such facsimile or electronic mail attached
signature page were an original thereof.

 

    	 	16	 

    	 	 	 

    

 

6.12.
Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and
the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and upon so
agreeing, shall incorporate such substitute provision in this Agreement.

 

6.13.
Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of
damages, the Investors and the Company will be entitled to specific performance under the Transaction Documents. The parties agree
that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described
in the foregoing sentence and hereby agrees to waive in any action for specific performance of any such obligation the defense
that a remedy at law would be adequate.

 

6.14.
Further Assurances. The parties shall execute and deliver all such further instruments and documents and take all such
other actions as may reasonably be required to carry out the transactions contemplated hereby and to evidence the fulfillment
of the agreements herein contained.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGES FOLLOW]

 

    	 	17	 

    	 	 	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

	 	TAOPING
    INC.
	 	 
	 	By:	 
	 	Name:	Jianghuai
    Lin
	 	Title:
    	Chief
    Executive Officer

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK

SIGNATURE PAGE FOR INVESTORS FOLLOWS]

 

    	 	 	 

    	 	 	 

    

 

IN
WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed by their respective authorized
signatories as of the date first indicated above.

 

	 	NAME
    OF INVESTOR
	 	 
		____________________________________________ 
	 	Name:
	 	Tax
    ID No. (if any):______________________________
	 	 
	 	Subscription
    Amount: ___________________________
	 	 
	 	Number
    of Shares:_______________________________
	 	 
	 	ADDRESS
    FOR NOTICE
	 	 
	 	c/o:__________________________________________
	 	 
	 	Street:
    ________________________________________
	 	 
	 	City/State/Country/Zip:___________________________
	 	 
	 	Attention:_____________________________________
	 	 
	 	Email:________________________________________
	 	 
	 	Tel:__________________________________________
	 	 
	 	Fax:__________________________________________
	 	 
	 	DELIVERY
    INSTRUCTIONS
	 	(if
    different from above)
	 	 
	 	c/o:________________________________________
	 	 
	 	Street:______________________________________
	 	 
	 	City/State/Country/Zip:_________________________
	 	 
	 	Attention:___________________________________
	 	 
	 	Tel:________________________________________Exhibit 10.1

 

FOMO
CORP.’S PURGE VIRUS PARTNERS WITH aGILE TECHNOLOGIES GROUP TO FIGHT COVID-19

 

Chicago,
IL, January 20, 2021 – FOMO CORP. (US OTC: ETFM) is pleased to announce that a Strategic Alignment Agreement has been
signed between its wholly owned subsidiary, Purge Virus, LLC (PV) and AGILE Technologies Group, LLC (AGILE), a provider of highly
accurate, FDA approved point-of-care rapid COVID-19 testing, technology-based screening, contact tracing, and COVID-19 safety
solutions. A description of AGILE’s current offerings is provided at http://www.4agiletech.com/, and PV’s germicidal
disinfection technology offerings are provided here: https://purgevirus.com/.

 

The
Agreement between PV and AGILE, effective for 2021, includes reciprocal business referrals with AGILE focusing on an integrated
solution for on-site rapid COVID-19 testing and disinfection technology, and PV focusing on supplying the most appropriate disinfection
technology to AGILE’s clients.

 

AGILE
has proven leadership in this new area of COVID-19 prevention with significant sales leadership, which has led to the purchase
of PV technologies such as disinfection devices with combinations of ultraviolet, carbon filtration, and HEPA filtration as well
as other devices including combinations of ultraviolet and photoplasma.

 

Clients
that have benefitted from the AGILE integrated solution with the PV disinfection technologies include: (a prominent Native American
tribe spanning Arizona and New Mexico, the City of Gary, Indiana, television production projects, movie production, professional
athlete weddings, churches, sound stages, legislative showcase, and testing events coordinated with government officials). One
client said “As we have utilized AGILE Technologies for the safety and prevention of this virus for our employees and guests,
we have developed a respect for the integrated innovation that provides a comfortable ecosystem of prevention. These innovations
and combinations have allowed us to work with assurance for safety.” Here is a summary of some of the most significant AGILE
COVID-19 testing events:

 

	 	●	City
    of Gary, Indiana:
	 	 	○	AGILE
    began testing city employees to help increase the quality and availability of municipal services and giving the city the data
    and controls to help manage the city’s workforce,
	 	 	○	AGILE
    has been asked to expand testing to include all 76,000 residents,
	 	 	○	AGILE
    had been asked to begin test for the Gary Housing Authority, Gary Public Transportation and critically needed warming centers
    during winter months.
	 	●	Navajo
    Nation (under contract with the Office of the Nation’s Controller):
	 	 	○	AGILE
    instituted a new, double rapid test methodology ,
	 	 	○	With
    the PV team, the safety solution includes HVAC-installed germicidal ultraviolet-C technology to eliminate coronavirus in the
    first six 30,000 square foot leadership and administration buildings for the Navajo Nation,
	 	 	○	Testing
    personnel wore Bipolar Ionization devices for a physical layer of protection ,
	 	 	○	The controller stated in a leadership meeting, “This
is the happiest that I have seen employees in months. They feel safer now than ever during the pandemic. And, if we become aware
that someone has been exposed, we know that AGILE can test everyone and identify anyone who should not be in the building until
after an isolation period.”

 

    	 	 	 

     

    

 

	 	●	High-profile
    wedding event of NBA player:
	 	 	○	240
    people tested including hotel staff, wedding/reception staff, vendors, wedding party and guests,
	 	 	 	■	AGILE
    was able to screen and prevent 27 infected individuals from attending the event with testing and screening,
	 	 	 	■	Three
    weeks after the wedding, the bride and groom reported that there were no reports of anyone contracting the disease.
	 	●	State
    Legislature and local municipal official COVID-19 testing event in an area with unconfirmed, high positivity rate:
	 	 	○	With
    a two-day notice, AGILE tested 100 people, identified 20 with active COVID-19 infection and was able to advise them to isolate
    to protect families, co-workers, and others.
	 	●	Sound
    Stage for a Christmas Show with a Grammy award winning entertainer:
	 	 	○	The
    entire production had been shut down twice for five days. AGILE assumed the COVID-19 safety scope of work and empowered the
    production team to continue production and filming to complete the television show with no additional breakages in production
    by identifying all infected actors, dancers, production staff, musicians, and other.
	 	●	Chicago
    CSO Sports Multiplex (80,000 square foot, multi-use facility):
	 	 	○	AGILE
    provided testing and air purification for over 500 basketball tournaments’ participants, volleyball and other sports
    skills camps and for individual personal trainers and all their clients.
	 	●	AGILE
    is modifying its website, sales/marketing materials and other information to give increased exposure to the air purification
    solutions offered by PV including sales directly from the PV website as many inquiries have been received about individual
    and business sales of the PV portable air purification systems.

 

The
combined work of AGILE and PV has helped to slow and stop potential super-spreader events, and the ongoing work is setting a new
precedent for testing, COVID-19 screening and indoor air safety.

 

“We
see tremendous potential in working with Purge Virus on accounts in the U.S. and around the world, given the number of areas that
are seeing surges in COVID-19 and the demand for rapid testing and indoor air disinfection,” said Roderick A. Martin, Chief
Managing Partner, AGILE Technologies Group, LLC.

 

“AGILE
expands the number of potential customers for our offerings with the addition of rapid testing, technology-based screening and
contact tracing and reinforces our mission to provide a ‘One-Stop-Shop’ for businesses and individuals who seek protection
from COVID-19 and future viruses. Our team has been impressed with AGILE’s ability to engage clients that see the value
of their integrated solution that provides rapid-testing, contact tracing, and our disinfection technologies,” said Charles
Szoradi, CEO of Purge Virus, LLC.

 

About
FOMO CORP.

 

FOMO
CORP., p/k/a 2050 Motors, Inc., is a publicly traded company focused on business incubation and acceleration. The Company invests
in and advises emerging companies aligned with a growth mandate. FOMO is developing direct investment and affiliations - majority-
and minority-owned as well as in joint venture formats - that afford emerging companies access to the public markets for expansion
capital as well as spin-out options to become their own stand-alone public companies.

 

    	 

    	 

    

 

Forward
Looking Statements:

 

Statements
in this press release about our future expectations, including without limitation, the likelihood that FOMO CORP. will be able
to meet minimum sales expectations, be successful and profitable in the market, bring significant value to FOMO CORP.’s
stockholders, and leverage capital markets to execute its growth strategy, constitute “forward-looking statements”
within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that
term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties
and are subject to change at any time, and our actual results could differ materially from expected results. The Company undertakes
no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after
the date of this statement or to reflect the occurrence of unanticipated events, except as required by law. FOMO’s business
strategy described in this press release is subject to innumerable risks, most significantly, whether the Company is successful
in securing adequate financing. No information in this press release should be construed in any form shape or manner as an indication
of the Company’s future revenues, financial condition, or stock price.

 

Contact:

 

Wayman
Baker, PhD

Exec
VP Corporate Development and Investor Relations

FOMO
CORP.

(630)
286-9560

IR@fomoworldwide.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]